MicroRNA‐mediated metabolic reprogramming of chimeric antigen receptor T cells - PMC

Seyed Mohammad Ali Hosseini Rad, Joshua Colin Halpin, Supannikar Tawinwung, Koramit Suppipat, Nattiya Hirankarn, Alexander D McLellan

pmc.ncbi.nlm.nih.gov·Read paper

Abstract

Advances made in chimeric antigen receptor (CAR) T cell therapy have revolutionized the treatment and management of certain cancers. Currently, B cell malignancies have been among the few cancers to which CAR T cells have shown persistent and ...

Make this part of your paper trail

Save this paper to a shelf, write a review, and keep your own notes.

Community Reviews

No reviews yet. Be the first to review this paper!